These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 539459)

  • 1. Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium.
    Ottesen B; Ulrichsen H; Wagner G; Fahrenkrug J
    Acta Physiol Scand; 1979 Nov; 107(3):285-87. PubMed ID: 539459
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
    Ottesen B; Wagner G; Fahrenkrug J
    Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB; Lang RJ; Ottesen B
    J Physiol; 1981 Sep; 318():41-55. PubMed ID: 7320897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of VIP in the female genital tract.
    Ottesen B; Fahrenkrug J; Wagner G; Ulrichsen H; Einer-Jensen N; Carter AM; Larsen JJ; Stolberg B
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():71-8. PubMed ID: 7227322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non-pregnant rabbit.
    Ottesen B; Fahrenkrug J
    Acta Physiol Scand; 1981 Jun; 112(2):195-201. PubMed ID: 7315413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of spironolactone on the contractions of the rabbit uterine horn and the human myometrial strip.
    Coksevim B; Tayyar M
    Indian J Physiol Pharmacol; 1994 Apr; 38(2):85-8. PubMed ID: 8063367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the spontaneous activity of the uterine muscle in vitro and in situ and its response to oxytocin.
    Chernaeva L
    Acta Physiol Pharmacol Bulg; 1976; 2(1):54-62. PubMed ID: 1035028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit.
    Hayashi K; Masuda K
    Jpn J Ophthalmol; 1982; 26(4):437-42. PubMed ID: 6187959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
    Lonovics J; Devitt P; Rayford PL; Thompson JC
    Surg Forum; 1979; 30():407-9. PubMed ID: 538649
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
    Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
    Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vasoactive intestinal polypeptide on uterine blood flow in pregnant ewes.
    Clark KE; Austin JE; Stys SJ
    Am J Obstet Gynecol; 1982 Nov; 144(5):497-502. PubMed ID: 7137236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
    Ryan J; Cohen S
    Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective new oxytocin inhibitors in tests on strips of the human uterus in vitro].
    Brest'ák M; Barth T; Rotta L; Servítová L; Jost K; Fuchs V
    Cesk Gynekol; 1984 Jul; 49(6):404-7. PubMed ID: 6488334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N; Yosida T; Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract]   [Full Text] [Related]  

  • 16. Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive intestinal polypeptide (VIP) [proceedings].
    Dodd J; Kelly JS; Said SI
    Br J Pharmacol; 1979 May; 66(1):125P. PubMed ID: 454920
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
    Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
    J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM; Ashton SH
    Fertil Steril; 1982 Jun; 37(6):845-50. PubMed ID: 7084506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries.
    Suzuki Y; Kobayashi Y; Lederis K
    Proc West Pharmacol Soc; 1983; 26():341-4. PubMed ID: 6889362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.